Company

talus.bio

Rocket Ship Rating

Rocket Ship Rating: 92 out of 100

One model for the full human proteome, including disordered targets beyond the reach of structure-based methods.

Also known as Talus Bioscience, Inc.

Biotech & therapeutics
AI native

Status: Operatingas of 2026-09-19
Business model: B2B
Headquarters: Seattle, United States
Customers: pharma partnerships
Legal name: Talus Bioscience, Inc.

Open relationship map

Claim, correct or request removal

Record updated 19 September 2026

About

Ptarmigan-1 predicts how proteins and small molecules engage without requiring a 3D structure or a known pocket.

Funding snapshot

Total raised: $11.2MSum of rounds, as of 2026-09-19Source (opens in a new tab)
Latest round: Undisclosed, $11.2M2024-08-20

Funding rounds

Round, 2024: $11.2M2024-08-20, Company stated
Round, 2024: $9.4M2024-07-29, SEC form D sold, 11 investors
Grant: 2023-08
Seed: 2022-06

Products

Web: Ptarmigan-1